Device Trial Radar · NCT07937683
Comparison of Three Treatments for Myofascial Pain in Patients With Bruxism
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
May 1, 2021
Primary completion
Oct 14, 2022
Study completion Oct 14, 2022
Sponsor
- Lead sponsor
- Saglik Bilimleri UniversitesiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compared three treatments for myofascial pain in adults with clinical features of bruxism, such as tooth clenching or grinding. Myofascial pain is pain arising from muscles and sensitive areas within them. Ninety adults aged 18-60 years were randomly assigned to one of three groups: dry needling, botulinum toxin type A injections, or an occlusal splint worn at night together with medication. Dry needling involved inserting thin needles into sensitive points in the masseter muscles. Botulinum toxin injections were administered into the masseter muscles on both sides. The splint group received tizanidine and paracetamol for one month. The study assessed pain at rest and during jaw function, sensitivity to pressure, and mouth opening. Assessments were performed before treatment and at one day, one week, and one month after treatment. The purpose was to compare the short-term effects of these three treatments.
Conditions
- Myofascial Pain - Dysfunction Syndrome of TMJ
- Bruxism
Interventions
Dry needlingProcedure
A single session of bilateral masseter dry needling was performed, targeting two or three active trigger points per muscle. Sterile, single-use acupuncture needles measuring 0.25 × 25 mm were inserted approximately 5 mm deep. Needles were briefly manipulated using rapid in-and-out movements and redirected within the trigger point region, then retained for 20 minutes.
Botulinium Toxin-ADrug
Botulinum toxin type A (Botox, Allergan) was administered into both masseter muscles during a single session. A 100-unit vial was reconstituted with 2.5 mL of sterile 0.9% saline. Each masseter received 20 units distributed across three injection sites, for a total dose of 40 units per participant. The needle was inserted at approximately 45 degrees to the skin surface.
Occlusal SplintDevice
A custom-made maxillary occlusal splint was fabricated from a 3-mm-thick polyvinyl acetate-polyethylene copolymer sheet using a vacuum-forming technique. Each splint was individually fitted and adjusted intraorally. Participants were instructed to wear the splint every night for one month.
TiZANidine 2 MG Oral CapsuleDrug
Tizanidine 2 mg was administered orally every 12 hours for one month as adjunctive pharmacotherapy in the occlusal splint group.
Paracetamol (500 mg) tabletsDrug
Paracetamol 500 mg was administered orally every 12 hours for one month as adjunctive pharmacotherapy in the occlusal splint group.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain Intensity at RestTime frame: Baseline (before treatment), Day 1, Week 1, and Month 1 after treatment.
- Pain Intensity During FunctionTime frame: Baseline (before treatment), Day 1, Week 1, and Month 1 after treatment.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Oral and Maxillofacial Surgery, Gülhane Faculty of Dentistry, University of Health Sciences
Ankara, Ankara, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.